Cargando…

Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma

BACKGROUND: Melanoma is a heterogeneous tumour, but the impact of this heterogeneity upon therapeutic response is not well understood. METHODS: Single cell mRNA analysis was used to define the transcriptional heterogeneity of melanoma and its dynamic response to BRAF inhibitor therapy and treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smalley, Inna, Kim, Eunjung, Li, Jiannong, Spence, Paige, Wyatt, Clayton J., Eroglu, Zeynep, Sondak, Vernon K., Messina, Jane L., Babacan, Nalan Akgul, Maria-Engler, Silvya Stuchi, De Armas, Lesley, Williams, Sion L., Gatenby, Robert A., Chen, Y. Ann, Anderson, Alexander R.A., Smalley, Keiran S.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838387/ https://www.ncbi.nlm.nih.gov/pubmed/31594749 http://dx.doi.org/10.1016/j.ebiom.2019.09.023

Ejemplares similares

Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma
por: Smalley, Keiran SM, et al.
Publicado: (2015)

BRAF inhibition generates a host/tumor niche that mediates therapeutic escape
por: Fedorenko, Inna V., et al.
Publicado: (2015)

LMD-03. Single cell analysis reveals how therapy remodels the tumor microenvironment in melanoma CNS metastases and uncovers a novel predictor of improved survival
por: Smalley, Inna, et al.
Publicado: (2021)

OTME-17. Single cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases
por: Smalley, Inna, et al.
Publicado: (2021)

SinCHet: a MATLAB toolbox for single cell heterogeneity analysis in cancer
por: Li, Jiannong, et al.
Publicado: (2017)

Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells
por: Fedorenko, Inna V., et al.
Publicado: (2015)

The complexity of microenvironment-mediated drug resistance
por: Fedorenko, Inna V., et al.
Publicado: (2015)

Beyond BRAF: where next for melanoma therapy?
por: Fedorenko, I V, et al.
Publicado: (2015)

Why do women with melanoma do better than men?
por: Smalley, Keiran SM
Publicado: (2018)

Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition
por: Phadke, Manali, et al.
Publicado: (2017)

XL888 limits vemurafenib-induced proliferative skin events by suppressing paradoxical MAPK activation
por: Phadke, Manali, et al.
Publicado: (2015)

Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma?
por: Faião-Flores, Fernanda, et al.
Publicado: (2019)

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
por: Paraiso, K H T, et al.
Publicado: (2010)

HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma
por: Sriramareddy, Sathya Neelature, et al.
Publicado: (2022)

Integrating BRAF/MEK inhibitors into combination therapy for melanoma
por: Smalley, K S M, et al.
Publicado: (2009)

Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanoma
por: Koomen, John M., et al.
Publicado: (2011)

Drepmel—A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment
por: Thompson, Zachary J., et al.
Publicado: (2022)

23. RETROSPECTIVE REVIEW OF ADULT PATIENTS WITH LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA AT MOFFITT CANCER CENTER: DIAGNOSIS, TREATMENT AND OUTCOMES
por: Pina, Yolanda, et al.
Publicado: (2020)

LPTO-03. IN-VITRO & IN-VIVO CULTURE OF PATIENT (PT) DERIVED CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES
por: Law, Vincent, et al.
Publicado: (2019)

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
por: Law, Vincent, et al.
Publicado: (2021)

LMD-05. Phase 1B Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD): Preliminary Results
por: Pina, Yolanda, et al.
Publicado: (2021)

Acral melanoma: new insights into the immune and genomic landscape
por: Carvalho, Larissa Anastacio DaCosta, et al.
Publicado: (2023)

TIPS-04 A RANDOMIZED, MULTI-INSTITUTIONAL PILOT STUDY TO EVALUATE THE MOLECULAR AND CELLULAR RESPONSE TO TREATMENT WITH NIVOLUMAB WITH EITHER ADJUVANT IPILIMUMAB OR RELATLIMAB IN ADULT PATIENTS WITH SURGICALLY RESECTABLE MELANOMA BRAIN METASTASES: ONGOING TRIAL
por: Pina, Yolanda, et al.
Publicado: (2023)

Dual Effect of Serum Amyloid A on the Invasiveness of Glioma Cells
por: Knebel, Franciele Hinterholz, et al.
Publicado: (2013)

SYST-03 PHASE 1B STUDY OF AVELUMAB AND WHOLE BRAIN RADIOTHERAPY (WBRT) IN PATIENTS WITH LEPTOMENINGEAL DISEASE (LMD) FROM EPITHELIAL CARCINOMAS: FINAL RESULTS AND MOLECULAR ANALYSES WITH SINGLE CELL RNA SEQUENCING
por: Pina, Yolanda, et al.
Publicado: (2023)

Treatment Approaches in 102 Elderly Patients With Non-Small Cell Lung Cancer
por: Cihan, Sener, et al.
Publicado: (2015)

Development of Epidermal Equivalent from Electrospun Synthetic Polymers for In Vitro Irritation/Corrosion Testing
por: Camarena, Denisse Esther Mallaupoma, et al.
Publicado: (2020)

K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling
por: Yin, Qing, et al.
Publicado: (2019)

In Vivo Acute Toxicity Studies of Novel Anti-Melanoma Compounds Downregulators of hnRNPH1/H2
por: Velayutham, Sadeeshkumar, et al.
Publicado: (2023)

A Case of Multifocal Skin Metastases from Lung Cancer Presenting with Vasculitic-type Cutaneous Nodule
por: Babacan, Nalan Akgul, et al.
Publicado: (2015)

Curcumin Analog DM-1 in Monotherapy or Combinatory Treatment with Dacarbazine as a Strategy to Inhibit In Vivo Melanoma Progression
por: Faião-Flores, Fernanda, et al.
Publicado: (2015)

Propolis Reduces the Expression of Autophagy-Related Proteins in Chondrocytes under Interleukin-1β Stimulus
por: Arias, Consuelo, et al.
Publicado: (2019)

Skin Irritation Testing beyond Tissue Viability: Fucoxanthin Effects on Inflammation, Homeostasis, and Metabolism
por: Spagolla Napoleão Tavares, Renata, et al.
Publicado: (2020)

Tissue Engineering Challenges for Cultivated Meat to Meet the Real Demand of a Global Market
por: Santos, Andressa Cristina Antunes, et al.
Publicado: (2023)

Redox-Related Proteins in Melanoma Progression
por: Carvalho, Larissa A. C., et al.
Publicado: (2022)

English friars and antiquity, the early fourteenth century
por: Smalley,Beryl
Publicado: (1960)

Analysing metaphorical pebbles in English RE
por: Smalley, Paul
Publicado: (2022)

3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells
por: Vital, Patrik da Silva, et al.
Publicado: (2022)

Nonsentinel Node Metastases in Melanoma: Do They Reflect the Biology of the Tumor, the Lymph Node or the Surgeon?: Editorial to Accompany Ghaferi et al., ASO-2009-03-0312.R1
por: Sondak, Vernon K.
Publicado: (2009)

Mesenchymal stem cells express epidermal markers in an in vitro reconstructed human skin model
por: Dos Santos, Jeniffer Farias, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vh2ae3bgms5qu34nd6gcpcvub7